Cellular immune responses to Neisseria meningitidis in children

Infection and Immunity

Volumn 67, Issue 5, 1999, Pages 2452-2463

  Pollard, Andrew J ^a   Galassini, Rachel ^a   Van Rouppe Der Voort, Eileene M ^a   Hibberd, Martin ^a   Booy, Robert ^a   Langford, Paul ^a   Nadel, Simon ^a   Ison, Catherine ^a   Kroll, J Simon ^a   Poolman, Jan ^b,c   Levin, Michael ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; OUTER MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOSTIMULATION; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL;

EID: 0032929407     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.5.2452-2463.1999     Document Type: Article

References (67)

1. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
2. Abdillahi, H., and J. T. Poolman. 1988. Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA. Microb. Pathog. 4:27-32.
3. Abdillahi, H., and J. T. Poolman. 1987. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett. 48: 367-371.
4. Ala'Aldeen, D. A. 1996. Transferrin receptors of Neisseria meningitidis: promising candidates for a broadly cross-protective vaccine. J. Med. Microbiol. 44:237-243.
5. Anonymous. 1997. 1995 communicable disease statistics, vol. 22. Office of National Statistics, HMSO Books, London, United Kingdom.
6. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and K. H. Mills. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or ThO. Immunology 87:372-380.
7. Bjune, G., E. A. Hoiby, J. K. Gronnesby, O. Arnesen, J. H. Fredriksen, A. Halstensen, E. Holten, A. K. Lindbak, H. Nokleby, E. Rosenqvist, et al. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
8. Boslego, J., J. Garcia, C. Cruz, W. Zollinger, B. Brandt, S. Ruiz, M. Martinez, J. Arthur, P. Underwood, W. Silva, et al. 1995. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Vaccine 13:821-829.
9. Bradford, M. M. 1976. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
10. Briere, F., C. Servet Delprat, J. M. Bridon, J. M. Saint-Remy, and J. Banchereau. 1994. Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J. Exp. Med. 179:757-762.
11. Burchett, S. K., L. Corey, K. M. Mohan, J. Westall, R. Ashley, and C. B. Wilson. 1992. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J. Infect. Dis. 165:813-818.
12. CDSC (Communicable Disease Surveillance Centre). 1998. Notifications of infectious diseases. Communicable Dis. Rep. 8:17-20.
13. Chheda, S., K. H. Palkowetz, R. Garofalo, D. K. Rassin, and A. S. Goldman. 1996. Decreased interleukin-10 production by neonatal monocytes and T cells: relationship to decreased production and expression of tumor necrosis factor-alpha and its receptors. Pediatr. Res. 40:475-483.
14. Claassen, I., J. Meylis, P. van der Ley, C. Peeters, H. Brons, J. Robert, D. Borsboom, A. van der Ark, I. van Straaten, P. Roholl, B. Kuipers, and J. Poolman. 1996. Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine 14:1001-1008.
15. de Moraes, J. C., B. A. Perkins, M. C. Camargo, N. T. Hidalgo, H. A. Barbosa, C. T. Sacchi, I. M. Landgraf, V. L. Gattas, H. D. G. Vasconcelos, I. M. Gral, et al. 1992. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 340:1074-1078.
16. Durandy, A., G. De Saint Basile, B. Lisowska-Grospierre, J. F. Gauchat, M. Forveille, R. A. Kroczek, J. Y. Bonnefoy, and A. Fischer. 1995. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J. Immunol. 154:1560-1568.
17. Ehlers, S., and K. A. Smith. 1991. Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J. Exp. Med. 173:25-36.
18. Fairley, C. K., N. Begg, R. Borrow, A. J. Fox, D. M. Jones, and K. Cartwright. 1996. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J. Infect. Dis. 174:1360-1363.
19. Frasch, C. E. 1989. Vaccines for prevention of meningococcal disease. Clin. Microbiol. Rev. 2(Suppl.):S134-S138.
20. Frasch, C. E., and L. F. Mocca. 1982. Strains of Neisseria meningitidis isolated from patients and their close contacts. Infect. Immun. 37:155-159.
21. Fredriksen, J. H., E. Rosenqvist, E. Wedege, K. Bryn, G. Bjunc, L. O. Froholm, A. K. Lindbak, B. Mogster, E. Namork, U. Rye, et al. 1991. Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 14:67-79, 79-80.
22. Frenkel, L., and Y. J. Bryson. 1987. Ontogeny of phytohemagglutinin-induced gamma interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age. J. Pediatr. 111:97-100.
23. Fuleihan, R., D. Ahern, and R. S. Geha. 1994. Decreased expression of the ligand for CD40 in newborn lymphocytes. Eur. J. Immunol. 24:1925-1928.
24. Glode, M. P., J. B. Robbins, T. Y. Liu, E. C. Gotschlich, I. Orskov, and F. Orskov. 1977. Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J. Infect. Dis. 135:94-104.
25. Greenberg, D. P., J. M. Lieberman, S. M. Marcy, V. K. Wong, S. Partridge, S. J. Chang, C. Y. Chiu, and J. I. Ward. 1995. Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccines. J. Pediatr. 126:206-211.
26. Hassan, J., and D. J. Reen. 1996. Reduced primary antigen-specific T-cell precursor frequencies in neonates are associated with deficient interleukin-2 production. Immunology 87:604-608.
27. Havens, P. L., J. S. Garland, M. M. Brook, B. A. Dewitz, E. S. Stremski, and T. J. Troshynski. 1989. Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987. Pediatr. Infect. Dis. J. 8:8-11.
28. Hayward, A. R., and J. Kurnick. 1981. Newborn T cell suppression: early appearance, maintenance in culture, and lack of growth factor suppression. J. Immunol. 126:50-53.
29. Hazelzet, J. A., I. M. Risseeuw-Appel, R. F. Kornelisse, W. C. Hop, I. Dekker, K. F. Joosten, R. de Groot, and C. E. Hack. 1996. Age-related differences in outcome and severity of DIC in children with septic shock and purpura. Thromb. Haemost. 76:932-938.
30. Holten, E. 1979. Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. J. Clin. Microbiol. 9:186-188.
31. Kawano, Y., T. Noma, and J. Yata. 1994. Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J. Immunol. 153:4948-4958.
32. Klouche, M., D. Wilhelm, and H. Kirchner. 1994. Cytokines, immunoglobulins, and IgG subclasses in patients with IgG plasmacytomas. Immun. Infekt. 22:149-151.
33. Lewis, D. B., K. S. Prickett, A. Larsen, K. Grabstein, M. Weaver, and C. B. Wilson. 1988. Restricted production of interleukin 4 by activated human T cells. Proc. Natl. Acad. Sci. USA 85:9743-9747.
34. Lewis, D. B., C. C. Yu, J. Meyer, B. K. English, S. J. Kahn, and C. B. Wilson. 1991. Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J. Clin. Investig. 87:194-202.
35. Lieberman, J. M., S. S. Chiu, V. K. Wong, S. Partidge, S. J. Chang, C. Y. Chiu, L. L. Gheesling, G. M. Carlone, and J. I. Ward. 1996. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial. JAMA 275:1499-1503.
36. Lifely, M. R., and Z. Wang. 1988. Immune responses in mice to different noncovalent complexes of meningococcal B polysaccharide and outer membrane proteins. Infect. Immun. 56:3221-3227.
37. Lilic, D., A. J. Cant, M. Abinun, J. E. Calvert, and G. P. Spickett. 1997. Cytokine production differs in children and adults. Pediatr. Res. 42:237-240.
38. Marchant, A., C. Bruyns, P. Vandenabeele, M. Ducarme, C. Gerard, A. Delvaux, D. De Groote, D. Abramowicz, T. Velu, and M. Goldman. 1994. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24:1167-1171.
39. McGuiness, B., A. K. Barlow, I. N. Clarcke, J. E. Parley, A. Anilionis, J. T. Poolman, and J. E. Heckels. 1990. Comparative sequence analysis of the class I protein gene (porA) from three strains of Neisseria meningitidis: synthetic peptides define the epitopes responsible for serosubtype specificity. J. Exp. Med. 171:1871.
40. McGuinness, B. T., I. N. Clarke, P. R. Lambden, A. K. Barlow, J. T. Poolman, D. M. Jones, and J. E. Heckels. 1991. Point mutation in meningococcal por A gene associated with increased endemic disease. Lancet 337:514-517.
41. Naess, L. M., F. Oftung, A. Aase, L. M. Wetzler, R. Sandin, and T. E. Michaelsen. 1998. Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine. Infect. Immun. 66:959-965.
42. Noah, N., and M. Connolly. 1996. Surveillance of bacterial meningitis in Europe 1995. King's European Meningitis Surveillance Unit, London, United Kingdom.
43. Peeters, C. C., H. C. Rumke, L. C. Sundermann, E. M. Rouppe van der Voort, J. Meulenbelt, M. Schuller, A. J. Kuipers, P. van der Ley, and J. T. Poolman. 1996. Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccine. Vaccine 14:1009-1015.
44. Petrov, A. B., B. F. Semenov, Y. P. Vartanyan, M. M. Zakirov, V. P. Torchilin, V. S. Trubetskoy, N. V. Koshkina, V. L. L'Vov, I. K. Verner, I. V. Lopyrev, et al. 1992. Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes. Infect. Immun. 60:3897-3903.
45. Platt, M. 1997. Child health statistical review. Arch. Dis. Child. 77:542-548.
46. Pollack, M. M., U. E. Ruttimann, and P. R. Getson. 1988. Pediatric risk of mortality (PRISM) score. Crit. Care Med. 16:1110-1116.
47. Pollard, A. J., R. Galassini, E. M. Rouppe van der Voort, R. Booy, P. Langford, S. Nadel, C. Ison, J. S. Kroll, J. Poolman, and M. Levin. 1999. Humoral immune responses to Neisseria meningitidis in children. Infect. Immun. 67:2441-2451.
48. Ramsay, M., E. Kaczmarski, M. Rush, R. Mallard, P. Farrington, and J. White. 1997. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Communicable Dis. Rep. Rev. 7:R49-R54.
49. Rouppe van der Voort, E. M., P. van der Ley, J. van der Biezen, S. George, O. Tunnela, H. van Dijken, B. Kuipers, and J. Poolman. 1996. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine. Infect. Immun. 64: 2745-2751.
50. Rouppe van der Voort, E. M., H. van Dijken, B. Kuipers, J. van der Biezen, P. van der Ley, J. Meylis, I. Claassen, and J. Poolman. 1997. Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine. Infect. Immun. 65:5184-5190.
51. Ryan, M., G. Murphy, E. Ryan, L. Nilsson, F. Shackley, L. Gothefors, K. Oymar, E. Miller, J. Storsaeter, and K. H. Mills. 1998. Distinct T-cell subtypes induced with whole cell and accellular pertussis vaccines in children. Immunology 93:1-10.
52. Shu, U., C. E. Demeure, D. G. Byun, F. Podlaski, A. S. Stern, and G. Delespesse. 1994. Interleukin 12 exerts a differential effect on the maturation of neonatal and adult human CD45R0-CD4 T cells. J. Clin. Investig. 94:1352-1358.
53. Sierra, G. V., H. C. Campa, N. M. Varcacel, I. L. Garcia, P. L. Izquierdo, P. F. Sotolongo, G. V. Casanueva, C. O. Rico, C. R. Rodriguez, and M. H. Terry. 1991. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195-207, 208-210.
54. Splawski, J. B., and P. E. Lipsky. 1991. Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes. J. Clin. Investig. 88:967-977.
55. Sullender, W. M., J. L. Miller, L. L. Yasukawa, J. S. Bradley, S. B. Black, A. S. Yeager, and A. M. Arvin. 1987. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J. Infect. Dis. 155: 28-37.
56. Tappero, J., R. Lagos, A. Maldonado, P. Herrera, L. Gheesling, D. Williams, G. Carlone, B. Plikaytis, H. Nokleby, J. Holst, G. Sierra, and B. Perkins. 1996. Serum bactericidal activity elicited by two outer membrane protein serogroup B meningococcal vaccines among infants, pre-school children, and adults in Santiago, Chile. Neisseria '96, 110th International Pathogenic Neisseria Conference, Baltimore, Md.
57. Tommassen, J., P. Vermeij, M. Struyve, R. Benz, and J. T. Poolman. 1990. Isolation of Neisseria meningitidis mutants deficient in class 1 (PorA) and class 3 (PorB) outer membrane proteins. Infect. Immun. 58:1355-1359.
58. Twumasi, P. A., Jr., S. Kumah, A. Leach, T. J. O'Dempsey, S. J. Ceesay, J. Todd, C. V. Broome, G. M. Carlone, L. B. Pals, P. K. Holder, et al. 1995. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J. Infect. Dis. 171:632-638.
59. Van Der Ley, P., and J. T. Poolman. 1992. Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein. Infect. Immun. 60:3156-3161.
60. Wetzler, L. M. 1994. Immunopotentiating ability of neisserial major outer membrane proteins. Use as an adjuvant for poorly immunogenic substances and potential use in vaccines. Ann. N. Y. Acad. Sci. 730:367-370.
61. Wetzler, L. M., Y. Ho, H. Reiser, and L. W. Wetzler. 1996. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J. Exp. Med. 183:1151-1159.
62. Wiertz, E. J., A. Delvig, E. M. Donders, H. F. Brugghe, L. M. van Unen, H. A. Timmermans, M. Achtman, P. Hoogerhout, and J. T. Poolman. 1996. T-cell responses to outer membrane proteins of Neisseria meningitidis: comparative study of the Opa, Opc, and PorA proteins. Infect. Immun. 64:298-304.
63. Wiertz, E. J., J. A. van Gaans-van den Brink, H. Gausepohl, A. Prochnicka-Chalufour, P. Hoogerhout, and J. T. Poolman. 1992. Identification of T cell epitopes occurring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis. J. Exp. Med. 176:79-88.
64. Wiertz, E. J., J. A. van Gaans-van den Brink, G. M. Schreuder, A. A. Termijtelen, P. Hoogerhout, and J. T. Poolman. 1991. T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements. J. Immunol. 147:2012-2018.
65. Wilson, C. B. 1991. The ontogeny of T lymphocyte maturation and function. J. Pediatr. 118:S4-S9.
66. Wu, C. Y., C. Demeure, M. Kiniwa, M. Gately, and G. Delespesse. 1993. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J. Immunol. 151:1938-1949.
67. Zollinger, W. D., R. E. Mandrell, J. M. Griffiss, P. Altieri, and S. Berman. 1979. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J. Clin. Investig. 63:836-848.